Northwestern Mutual Wealth Management Co. grew its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4,545.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 663,337 shares of the company's stock after acquiring an additional 649,058 shares during the period. Northwestern Mutual Wealth Management Co. owned 0.29% of HCA Healthcare worth $309,686,000 as of its most recent SEC filing.
Several other large investors have also modified their holdings of the company. Capital World Investors boosted its holdings in shares of HCA Healthcare by 3.8% during the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company's stock worth $2,113,662,000 after buying an additional 179,443 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of HCA Healthcare by 1.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company's stock worth $880,199,000 after buying an additional 36,414 shares during the period. Viking Global Investors LP boosted its holdings in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock worth $717,214,000 after buying an additional 690,773 shares during the period. Legal & General Group Plc boosted its holdings in shares of HCA Healthcare by 0.8% during the 3rd quarter. Legal & General Group Plc now owns 1,124,511 shares of the company's stock worth $479,267,000 after buying an additional 8,478 shares during the period. Finally, Invesco Ltd. boosted its holdings in shares of HCA Healthcare by 1.1% during the 3rd quarter. Invesco Ltd. now owns 1,100,929 shares of the company's stock worth $469,216,000 after buying an additional 11,829 shares during the period. 62.73% of the stock is owned by institutional investors.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. KeyCorp cut their target price on shares of HCA Healthcare from $550.00 to $510.00 and set an "overweight" rating for the company in a research note on Monday, April 27th. Truist Financial cut their target price on shares of HCA Healthcare from $546.00 to $535.00 and set a "buy" rating for the company in a research note on Monday, April 27th. Argus cut their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a "buy" rating for the company in a research note on Monday, May 4th. Mizuho upped their target price on shares of HCA Healthcare from $540.00 to $585.00 and gave the company an "outperform" rating in a research note on Wednesday, February 25th. Finally, JPMorgan Chase & Co. upped their target price on shares of HCA Healthcare from $420.00 to $535.00 and gave the company a "neutral" rating in a research note on Friday, February 20th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $517.82.
View Our Latest Stock Analysis on HCA
HCA Healthcare Stock Down 2.3%
Shares of HCA Healthcare stock opened at $422.68 on Friday. The stock has a market capitalization of $93.77 billion, a P/E ratio of 14.54, a price-to-earnings-growth ratio of 1.37 and a beta of 1.18. The company has a 50-day simple moving average of $478.74 and a 200 day simple moving average of $485.84. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company's revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter last year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 10.73%.
Insider Buying and Selling
In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the sale, the executive vice president owned 8,853 shares of the company's stock, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.50% of the stock is currently owned by corporate insiders.
About HCA Healthcare
(
Free Report)
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report